Page last updated: 2024-11-02

fenclonine and Carcinoma, Squamous Cell

fenclonine has been researched along with Carcinoma, Squamous Cell in 1 studies

Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasenack, U1
Caspary, W1

Other Studies

1 other study available for fenclonine and Carcinoma, Squamous Cell

ArticleYear
[Therapy of carcinoid and the carcinoid syndrome].
    Deutsche medizinische Wochenschrift (1946), 1983, Apr-29, Volume: 108, Issue:17

    Topics: Aminocaproic Acid; Aprotinin; Carcinoma, Squamous Cell; Cyproheptadine; Doxorubicin; Embolization, T

1983